PFND
PATHFINDER CELL THERAPY by Pathfinder Cell Therapy, Inc. (PFND)
$
00About PATHFINDER CELL THERAPY by Pathfinder Cell Therapy, Inc. (PFND)
Pathfinder Cell Therapy, Inc. is a development stage regenerative medicine company. It focuses on developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. The company was founded in August 1990 and is headquartered in Cambridge, MA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
700
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--
PATHFINDER CELL THERAPY by Pathfinder Cell Therapy, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
700
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--